Organization
Hospital Universitario Marqués de Valdecilla. IDIVAL., Rheumatology and Ophthalmology, Santander, Spain
1 abstract
Abstract
ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES’ ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICEOrg: Hospital Universitario Marqués de Valdecilla. IDIVAL., Rheumatology and Ophthalmology, Santander, Spain, Hospital Peset, Rheumatology, Valencia, Spain, Hospital Universitario de Donostia, Rheumatology and Ophthalmology, San Sebastián, Spain, Hospital Universitario de Basurto, Rheumatology and Ophthalmology, Bilbao, Spain, Hospital Virgen de la Salud, Rheumatology, Toledo, Spain,